|
1
|
Siegel R, Naishadham D, Jemal A, et al:
Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Almonte M, Bruni L, et al:
Burden and trends of type-specific human papillomavirus infections
and related diseases in the Latin America and Caribbean region.
Vaccine. 26:(Suppl 11). L1–L15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mathew A and George PS: Trends in
incidence and mortality rates of squamous cell carcinoma and
adenocarcinoma of cervix - worldwide. Asian Pac J Cancer Prev.
10:645–650. 2009.PubMed/NCBI
|
|
4
|
Vizcaino AP, Moreno V, Bosch FX, et al:
International trends in incidence of cervical cancer: II.
Squamous-cell carcinoma. Int J Cancer. 86:429–435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Richart RM: A modified terminology for
cervical intraepithelial neoplasia. Obstet Gynecol. 75:131–133.
1990.PubMed/NCBI
|
|
6
|
Mayr NA, Small W Jr and Gaffney DK:
Cervical cancerDecision Making in Radiation Oncology. Lu JJ and
Brady LW: 2. Springer-Verlag; Berlin Heidelberg: pp. 661–701.
2011
|
|
7
|
Kyrgiou M and Mahmood SI: Invasive cancer
of the cervix. Obstet Gynecol Reprod Med. 20:147–154. 2010.
View Article : Google Scholar
|
|
8
|
Wright TC Jr, Schiffman M, Solomon D, et
al: Interim guidance for the use of human papillomavirus DNA
testing as an adjunct to cervical cytology for screening. Obstet
Gynecol. 103:304–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baker JJ: Conventional and liquid-based
cervicovaginal cytology: a comparison study with clinical and
histologic follow-up. Diagn Cytopathol. 27:185–188. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Avall-Lundqvist EH, Sjövall K, Nilsson BR,
et al: Prognostic significance of pretreatment serum levels of
squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
Eur J Cancer. 28A:1695–1702. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bolli JA, Doering DL, Bosscher JR, et al:
Squamous cell carcinoma antigen: clinical utility in squamous cell
carcinoma of the uterine cervix. Gynecol Oncol. 55:169–173. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JW, Choi CH, Choi JJ, et al: Altered
microRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pereira PM, Marques JP, Soares AR, et al:
MicroRNA expression variability in human cervical tissues. PLoS
One. 5:e117802010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu X, Schwarz JK, Lewis JS Jr, et al: A
microRNA expression signature for cervical cancer prognosis. Cancer
Res. 70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang C, Wang C, Chen X, et al:
Identification of seven serum microRNAs from a genome-wide serum
microRNA expression profile as potential noninvasive biomarkers for
malignant astrocytomas. Int J Cancer. 132:116–127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Fang Z, Jiang T, et al: Serum
microRNAs profile from genome-wide serves as a fingerprint for
diagnosis of acute myocardial infarction and angina pectoris. BMC
Med Genomics. 6:162013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li LM, Hu ZB, Zhou ZX, et al: Serum
microRNA profiles serve as novel biomarkers for HBV infection and
diagnosis of HBV-positive hepatocarcinoma. Cancer Res.
70:9798–9807. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Hu Z, Wang W, et al:
Identification of ten serum microRNAs from a genome-wide serum
microRNA expression profile as novel noninvasive biomarkers for
nonsmall cell lung cancer diagnosis. Int J Cancer. 130:1620–1628.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu R, Zhang C, Hu Z, et al: A
five-microRNA signature identified from genome-wide serum microRNA
expression profiling serves as a fingerprint for gastric cancer
diagnosis. Eur J Cancer. 47:784–791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Wang C, Chen X, et al: Expression
profile of microRNAs in serum: a fingerprint for esophageal
squamous cell carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Li Q, Wang J, et al:
Identification and characterization of novel amphioxus microRNAs by
Solexa sequencing. Genome Biol. 10:R782009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X, Liang H, Guan D, et al: A
Combination of Let-7d, Let-7g and Let-7i serves as a stable
reference for normalization of serum microRNAs. PLoS ONE.
8:e79652(Epub ahead of print). doi. View Article : Google Scholar : 2013.PubMed/NCBI
|
|
25
|
Chim SS, Shing TK, Hung EC, et al:
Detection and characterization of placental microRNAs in maternal
plasma. Clin Chem. 54:482–490. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen X, Ba Y, Ma L, et al:
Characterization of microRNAs in serum: a novel class of biomarkers
for diagnosis of cancer and other diseases. Cell Res. 18:997–1006.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mitchell PS, Parkin RK, Kroh EM, et al:
Circulating microRNAs as stable blood-based markers for cancer
detection. Proc Natl Acad Sci USA. 105:10513–10518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cocucci E, Racchetti G and Meldolesi J:
Shedding microvesicles: artefacts no more. Trends Cell Biol.
19:43–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghosh AK, Secreto CR, Knox TR, et al:
Circulating microvesicles in B-cell chronic lymphocytic leukemia
can stimulate marrow stromal cells: implications for disease
progression. Blood. 115:1755–1764. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Valadi H, Ekström K, Bossios A, et al:
Exosome-mediated transfer of mRNAs and microRNAs is a novel
mechanism of genetic exchange between cells. Nat Cell Biol.
9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: a new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calin GA and Croce CM: MicroRNA-cancer
connection: the beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang H, Zuo Z, Lu X, et al: MiR-25
regulates apoptosis by targeting Bim in human ovarian cancer. Oncol
Rep. 27:594–598. 2012.PubMed/NCBI
|
|
35
|
Oh HK, Tan AL, Das K, et al: Genetic loss
of miR-486 regulates tumor progression and the OLMF4 antiapoptotic
factor in gastric cancer. Clin Cancer Res. 17:2657–2667. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Walboomers JM, Jacobs MV, Manos MM, et al:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martinez I, Gardiner AS, Board KF, et al:
Human papillomavirus type 16 reduces the expression of microRNA-218
in cervical carcinoma cells. Oncogene. 27:2575–2582. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Wang F, Xu J, et al: Progressive
miRNA expression profiles in cervical carcinogenesis and
identification of HPV-related target genes for miR-29. J Pathol.
224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
